ATE88896T1 - Topische behandlung von stoerungen kranker haut. - Google Patents

Topische behandlung von stoerungen kranker haut.

Info

Publication number
ATE88896T1
ATE88896T1 AT88308517T AT88308517T ATE88896T1 AT E88896 T1 ATE88896 T1 AT E88896T1 AT 88308517 T AT88308517 T AT 88308517T AT 88308517 T AT88308517 T AT 88308517T AT E88896 T1 ATE88896 T1 AT E88896T1
Authority
AT
Austria
Prior art keywords
compound
antiseptic
topical treatment
combination
disorders
Prior art date
Application number
AT88308517T
Other languages
English (en)
Inventor
Patrick A Beauchamp
James A Rogers
Original Assignee
Patrick A Beauchamp
James A Rogers
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Patrick A Beauchamp, James A Rogers filed Critical Patrick A Beauchamp
Application granted granted Critical
Publication of ATE88896T1 publication Critical patent/ATE88896T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/18—Iodine; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT88308517T 1987-09-16 1988-09-15 Topische behandlung von stoerungen kranker haut. ATE88896T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CA000546981A CA1273576A (en) 1987-09-16 1987-09-16 Topical treatment for diseased skin disorders
EP88308517A EP0308210B1 (de) 1987-09-16 1988-09-15 Topische Behandlung von Störungen kranker Haut

Publications (1)

Publication Number Publication Date
ATE88896T1 true ATE88896T1 (de) 1993-05-15

Family

ID=4136452

Family Applications (1)

Application Number Title Priority Date Filing Date
AT88308517T ATE88896T1 (de) 1987-09-16 1988-09-15 Topische behandlung von stoerungen kranker haut.

Country Status (6)

Country Link
US (1) US5753270A (de)
EP (1) EP0308210B1 (de)
JP (1) JP2668800B2 (de)
AT (1) ATE88896T1 (de)
CA (1) CA1273576A (de)
DE (1) DE3880769T2 (de)

Families Citing this family (70)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4992276A (en) * 1988-12-14 1991-02-12 Warner-Lambert Company Antiseptic compositions containing hexahydro-5-pyrimidinamine compounds and thymol and methods for preparing same
ES2140389T3 (es) * 1990-03-02 2000-03-01 Partnership Of Isaac G Eliaz A Procedimiento y producto para favorecer el crecimiento del cbaello y el tratamiento de la piel.
US6203782B1 (en) 1990-03-02 2001-03-20 Universal Biologics, Inc. Method and product for promoting hair growth and treating skin conditions
JP2693859B2 (ja) * 1990-09-28 1997-12-24 高砂香料工業株式会社 尋常性▲ざ▼瘡用皮膚外用剤
DE4319554C2 (de) * 1993-06-13 2002-03-14 Uwe R Juergens Verwendung von Menthol zur peroralen entzündungshemmenden Behandlung von Asthma bronchiale
NL9500216A (nl) * 1995-02-06 1996-09-02 Bio Pharma Sciences Bv Farmaceutische samenstelling voor de behandeling van herpes.
DE69837350T2 (de) * 1998-04-20 2007-11-29 Torrey Pines Institute For Molecular Studies, San Diego Topische immunostimulierung zur induzierung der migration der langerhanszellen
DE19834053A1 (de) * 1998-07-29 2000-03-30 Centeon Pharma Gmbh Verfahren und Mittel zur Sanatisierung von durch Viren verursachten Kontaminationen
DE19837549A1 (de) * 1998-08-19 2000-02-24 Beiersdorf Ag Verwendung quaternärer Stickstoffverbindungen zur Prophylaxe und Behandlung des superinfizierten Ekzems
US7229621B2 (en) 1998-10-20 2007-06-12 Torrey Pines Institute For Molecular Studies Method to enhance the immunogenicity of an antigen
WO2000025763A2 (de) * 1998-10-30 2000-05-11 Meckel-Spenglersan Gmbh Phenolderivaten enthaltendes mittel mit proliferationshemmender wirkung auf tumorzellen
JP4194196B2 (ja) 1999-02-22 2008-12-10 花王株式会社 浴用剤組成物
US8173709B2 (en) 1999-09-22 2012-05-08 Quadex Pharmaceuticals, Llc Anti-infective methods for treating pathogen-induced disordered tissues
US6211243B1 (en) 1999-09-22 2001-04-03 B. Ron Johnson Methods for treating cold sores with anti-infective compositions
US6759434B2 (en) 1999-09-22 2004-07-06 B. Ron Johnson Anti-infective compositions, methods and systems for treating disordered tissue
US6365215B1 (en) * 2000-11-09 2002-04-02 International Flavors & Fragrances Inc. Oral sensory perception-affecting compositions containing dimethyl sulfoxide, complexes thereof and salts thereof
FR2822070B1 (fr) * 2001-03-15 2006-01-06 Andre Salkin Utilisation d'un derive de biguanide et d'une pyrimidine pour la fabrication d'une composition de soin cosmetique
IL142812A (en) * 2001-04-25 2012-12-31 Israel State Highly effective anti-vasodilators and chemicals with high permeability
US6528076B2 (en) * 2001-07-06 2003-03-04 Magic Herb Corp. Topical compositions and methods for treating pain
US6894078B2 (en) * 2001-09-17 2005-05-17 James G. Castillo Alcohol based topical anesthetic formulation and method
US6846846B2 (en) 2001-10-23 2005-01-25 The Trustees Of Columbia University In The City Of New York Gentle-acting skin disinfectants
EP1480517A4 (de) * 2002-02-07 2007-08-22 Univ Columbia Zinksalzzusammensetzungen für die vorbeugung von schleimhautreizung durch spermizide und mikrobizide
US7879365B2 (en) * 2002-02-07 2011-02-01 The Trustees Of Columbia University In The City Of New York Zinc salt compositions for the prevention of dermal and mucosal irritation
US7435429B2 (en) * 2002-02-07 2008-10-14 Trustees Of Columbia University In The City Of New York Zinc salt compositions for the prevention of dermal and mucosal irritation
US7745425B2 (en) * 2002-02-07 2010-06-29 The Trustees Of Columbia University In The City Of New York Non-irritating compositions containing zinc salts
US7563461B2 (en) * 2002-02-07 2009-07-21 The Trustees Of Columbia University In The City Of New York Zinc salt compositions for the prevention of dermal and mucosal irritation
US7572469B2 (en) 2002-04-15 2009-08-11 Tetsuo Santo Therapeutic lotion for dermatitis
JP4515098B2 (ja) * 2002-04-15 2010-07-28 哲夫 山東 皮膚炎治療用クリーム
IL152486A0 (en) 2002-10-25 2003-05-29 Meir Eini Alcohol-free cosmetic and pharmaceutical foam carrier
US7700076B2 (en) 2002-10-25 2010-04-20 Foamix, Ltd. Penetrating pharmaceutical foam
US7704518B2 (en) 2003-08-04 2010-04-27 Foamix, Ltd. Foamable vehicle and pharmaceutical compositions thereof
US20080138296A1 (en) 2002-10-25 2008-06-12 Foamix Ltd. Foam prepared from nanoemulsions and uses
US9265725B2 (en) 2002-10-25 2016-02-23 Foamix Pharmaceuticals Ltd. Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
CA2502986C (en) 2002-10-25 2011-08-23 Foamix Ltd. Cosmetic and pharmaceutical foam
US9668972B2 (en) 2002-10-25 2017-06-06 Foamix Pharmaceuticals Ltd. Nonsteroidal immunomodulating kit and composition and uses thereof
US10117812B2 (en) 2002-10-25 2018-11-06 Foamix Pharmaceuticals Ltd. Foamable composition combining a polar solvent and a hydrophobic carrier
US20070053848A1 (en) * 2003-08-26 2007-03-08 Stockel Richard F Antimicrobial materials for dental care applications
US7132452B2 (en) * 2003-03-10 2006-11-07 Fang-Yu Lee Topical formulation having effects on alleviating pain/inflammation caused by herpes virus infection
US7871649B2 (en) 2003-07-17 2011-01-18 The Trustees Of Columbia University In The City Of New York Antimicrobial compositions containing synergistic combinations of quaternary ammonium compounds and essential oils and/or constituents thereof
US20050136024A1 (en) * 2003-12-22 2005-06-23 Stockel Richard F. Dermatological compositions
US10918618B2 (en) 2005-03-10 2021-02-16 3M Innovative Properties Company Methods of reducing microbial contamination
US20060263452A1 (en) * 2005-05-17 2006-11-23 Alwyn Dowell Topical composition containing essential oils
US8512724B2 (en) 2005-06-10 2013-08-20 The Board Of Regents Of The University Of Texas System Antiseptic compositions
US7759327B2 (en) * 2006-01-06 2010-07-20 The Trustees Of Columbia University In The City Of New York Compositions containing zinc salts for coating medical articles
US20080260655A1 (en) 2006-11-14 2008-10-23 Dov Tamarkin Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses
US8636982B2 (en) 2007-08-07 2014-01-28 Foamix Ltd. Wax foamable vehicle and pharmaceutical compositions thereof
GB0722349D0 (en) * 2007-11-15 2007-12-27 Reckitt Benckiser Healthcare Use of anti-bacterial compounds having an anaesthetic effect
WO2009069006A2 (en) 2007-11-30 2009-06-04 Foamix Ltd. Foam containing benzoyl peroxide
WO2009090495A2 (en) 2007-12-07 2009-07-23 Foamix Ltd. Oil and liquid silicone foamable carriers and formulations
WO2009088826A1 (en) * 2007-12-31 2009-07-16 3M Innovative Properties Company Liquid antiseptic compositions containing iodine and a sugar and/or sugar alcohol
CA2760186C (en) 2009-04-28 2019-10-29 Foamix Ltd. Foamable vehicle and pharmaceutical compositions comprising aprotic polar solvents and uses thereof
WO2011013009A2 (en) 2009-07-29 2011-02-03 Foamix Ltd. Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses
CA2769677A1 (en) 2009-07-29 2011-02-03 Foamix Ltd. Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses
US9849142B2 (en) 2009-10-02 2017-12-26 Foamix Pharmaceuticals Ltd. Methods for accelerated return of skin integrity and for the treatment of impetigo
CA2776366C (en) 2009-10-02 2017-07-18 Foamix Ltd. Surfactant-free water-free foamable compositions, breakable foams and gels and their uses
US8846725B2 (en) * 2011-01-24 2014-09-30 Quadex Pharmaceuticals, Llc Highly penetrating compositions and methods for treating pathogen-induced disordered tissues
US20120225143A1 (en) * 2011-03-03 2012-09-06 Ranir, Llc Cold sore formulation and related method of manufacture
BR112014013610B1 (pt) * 2011-12-06 2020-12-29 Unilever Nv composição antimicrobiana compreendendo timol, método não terapêutico de desinfecção de uma superfície e uso não terapêutico de uma composição
WO2013122637A1 (en) * 2012-02-17 2013-08-22 Capriotti Joseph Antifungal compositions for the treatment of skin and nails
US9125911B2 (en) 2013-03-14 2015-09-08 Quadex Pharmaceuticals, Llc Combined systemic and topical treatment of disordered tissues
US9549930B2 (en) 2013-03-14 2017-01-24 Quadex Pharmaceuticals, Llc Combined systemic and topical treatment of disordered and/or prodromal stage tissue
US9463180B2 (en) 2013-03-14 2016-10-11 Quadex Pharmaceuticals, Llc Treatment of molluscum contagiosum
RU2560674C1 (ru) * 2014-02-21 2015-08-20 Общество с ограниченной ответственностью "Инновации ветеринарии" (ООО "ИнВет") Универсальное антибактериальное средство
JP6843774B2 (ja) * 2015-06-23 2021-03-17 ファーティマ・ベナジール・ジャハンギル・アリ 生体試料の染色のための植物ベース色素、その抽出方法及び使用
UA118192C2 (uk) 2015-10-22 2018-12-10 Юрій Захарович Толчеєв Противірусна фармацевтична композиція
US20170266090A1 (en) * 2016-03-17 2017-09-21 Marvel Technologies Usa, Llc Antimicrobial compositions that are dermatologically non-drying
WO2017195783A1 (ja) * 2016-05-09 2017-11-16 株式会社ナノエッグ アトピー性皮膚炎を治療または予防するための組成物
MX2017011630A (es) 2016-09-08 2018-09-25 Foamix Pharmaceuticals Ltd Composiciones y metodos para tratar rosacea y acne.
CN108186660A (zh) * 2018-03-29 2018-06-22 刘春霞 一种消肿西药软膏
RU2760683C1 (ru) * 2021-05-25 2021-11-29 Федеральное государственное бюджетное образовательное учреждение высшего образования "Саратовский государственный аграрный университет имени Н.И. Вавилова" Средство для дезинфекции

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US54763A (en) * 1866-05-15 Improvement i
US608612A (en) * 1898-08-09 Friedbich wiliielm klever
DE389778C (de) * 1920-10-12 1924-02-07 Chemia Ungarische Chemische In Verfahren zur Darstellung fester Jodloesungen
US1676554A (en) * 1925-07-06 1928-07-10 Hoopman Aldus Arthur Topical medicine
US4294852A (en) * 1973-11-01 1981-10-13 Johnson & Johnson Skin treating compositions
US4390539A (en) * 1979-04-13 1983-06-28 George F. And Irene Sherrill 1978 Trust No. 1 Method for the treatment of viral skin diseases
US4262007A (en) * 1979-04-13 1981-04-14 George F. Sherrill Method for the treatment of viral skin diseases
US4466956A (en) * 1981-10-28 1984-08-21 Robert Leeds Method of therapy for oral herpes simplex
DE3234350A1 (de) * 1982-09-16 1984-03-22 Roland 3400 Göttingen Hemmann Verfahren zur herstellung eines keimtoetenden und oberflaechenanaesthesierenden heilmittels
FR2589061B1 (fr) * 1985-10-25 1987-11-27 Garcia Micheline Procede de fabrication de produit hygienique pour equides a base d'iode bisublimee

Also Published As

Publication number Publication date
JP2668800B2 (ja) 1997-10-27
CA1273576A (en) 1990-09-04
EP0308210B1 (de) 1993-05-05
DE3880769T2 (de) 1993-11-11
DE3880769D1 (de) 1993-06-09
EP0308210A1 (de) 1989-03-22
US5753270A (en) 1998-05-19
JPH01151522A (ja) 1989-06-14

Similar Documents

Publication Publication Date Title
ATE88896T1 (de) Topische behandlung von stoerungen kranker haut.
US4607101A (en) Method of treating acne vulgaris with a composition containing carbamide peroxide
DE3528979C2 (de)
ATE64297T1 (de) Aufspruehbare pharmazeutische zubereitung fuer die topische anwendung.
KR880000091A (ko) 국소용 약제학적 조성물 이의 제조방법 및 이의 용도
ATE76306T1 (de) Pharmazeutische loesungen die dimethylsulfoxid enthalten.
ATE16191T1 (de) Stabile salze von s-adenosinylmethionin, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen welche als aktive substanz diese derivate enthalten.
DE3413052A1 (de) Pharmazeutische zubereitung und deren verwendung zur behandlung von hauterkrankungen
KR900017590A (ko) 좌창(Acne)치료방법 및 그 약제 조성물
DE3582439D1 (de) Mittel zur behandlung von herzerkrankungen.
ES2170813T3 (es) Acidos 2,2-dicloroalcanocarboxilicos, proceso para su preparacion, medicamentos que los contienen y su uso para tratar la resistencia a la insulina.
DE60004786T2 (de) Verfahren und zusammensetzung zur behandlung von akne
DE58901002D1 (de) Mittel mit zerstoerender wirkung auf maligne tumore, verfahren zu dessen herstellung und praeparation zur anwendung in der therapie von krebskranken.
Suringa Treatment of superficial onychomycosis with topically applied glutaraldehyde: A preliminary study
US4039664A (en) Topical griseofulvin composition and method
NO166939C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive carboxylsyrederivater.
IT1170214B (it) Composizione farmaceutica per la cura delle arteriopatie periferiche
ATE51343T1 (de) Abwaschbare topische zubereitung zur therapie der psoriasis.
EP0584126B1 (de) Lanolinderivate als penetrationsfördernde substanzen
EP0016183A1 (de) Medikation für haut- und schleimhaut-leiden
US3790682A (en) Ataractic use of dimethyl sulfoxide
EP0086228B1 (de) Verwendung von carbamidperoxid zur herstellung eines arzneimittels zur behandlung von akne vulgaris
SE8501518D0 (sv) Pharmazeutische preparate
SMITH et al. Resin of Podophyllum in Treatment of Cancerous and Precancerous Conditions of Skin: Effect on Basal Cell Epithelioma and Seborrheic, Senile and Radiation Keratoses
DE4315866C1 (de) Äußerliche Zubereitungen zur Therapie von Hauterkrankungen mit Photosensibilisatoren